Clinical and economic burden of otitis media in children under 5 years of age in the United States: A retrospective studyHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52024-10-180OAAI
The Incidence of Skin and Soft Tissue Infections in the United States and Associated Healthcare Utilization Between 2010 and 2020OPEN FORUM INFECTIOUS DISEASESIF3.82024-05-079OAAI
Systematic review of the efficacy, effectiveness and impact of high-valency pneumococcal conjugate vaccines on otitis mediaHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52022-01-127OAAI
A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian childrenHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52021-08-265OAAI
Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label studyHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52020-08-264OAAI
Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label studyHUMAN VACCINES & IMMUNOTHERAPEUTICSIF3.52020-02-124OAAI
SEROTYPES OF STREPTOCOCCUS PNEUMONIAE IN CHILDREN OF RUSSIAN FEDERATIONPEDIATRIC RESEARCHIF3.12011-11-010OAAI